EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance

Yasuo Tsunetoshi, Fumihiro Sanada iD, Yuko Kanemoto, Kana Shibata, Atsushi Masamune, Yoshiaki Taniyama iD, Koichi Yamamoto iD, Ryuichi Morishita

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252313205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yasuo Tsunetoshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric and General Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Cell Adhesion Molecules, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI Grant, G7 Foundation, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) characterized by an abundant cancer stroma is an aggressive malignancy with a poor prognosis. Periostin (Pn) is a key extracellular matrix (ECM) protein in various tumor progression. Previously, we described the role of Pn alternative splicing variants (ASVs) with specific functional features in breast cancer. Pn is known to associate with a chemoresistance of PDAC, but the functions of the Pn-ASVs remain largely unknown. In this study, we focused on physiological and pathological Pn-ASVs, and examined the characteristics of Pn-expressing cells and the difference in function of each ASV. We found that cancer-associated fibroblasts (CAFs) are a main source of Pn synthesis, which selectively secrete pathological Pn-ASVs with exon 21 both in mouse and human samples. RNA sequencing identified a gene signature of Pn-positive CAFs associated with ECM-related genes and chemokines, factors that shape the chemoresistance tumor microenvironment (TME). Additionally, only pathological Pn-ASVs interacted with heat shock protein 70-1a (HSP70-1a), leading to significant rescue of gemcitabine-induced PDAC apoptosis. In silico analysis revealed that the presence or absence of exon 21 changes the tertiary structure of Pn and the binding sites for HSP70-1a. Altogether, Pn-ASVs with exon 21 secreted from CAFs play a key role in supporting tumor growth by interacting with cancer cell-derived HSP70-1a, indicating that Pn-ASVs with exon 21 might be a potential therapeutic and diagnostic target in PDAC patients with rich stroma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmCell Adhesion MoleculesPancreatic NeoplasmsCarcinoma, Pancreatic DuctalCancer-Associated FibroblastsAlternative SplicingGemcitabineHumansAnimalsMiceTumor MicroenvironmentDisease ProgressionHSP70 Heat-Shock ProteinsDeoxycytidineCell Line, TumorGene Expression Regulation, NeoplasticApoptosisPeriostin

Stichwörter der Autor:innen

alternative splicing variantsextracellular matrix proteinpancreatic cancersperiostin

Substanzen

Cell Adhesion MoleculesPOSTN protein, humanGemcitabineHSP70 Heat-Shock ProteinsDeoxycytidinePostn protein, mousePeriostin

Autor:innen und Institutionen

  • Department of Geriatric and General Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
  • Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
  • Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
  • Department of Advanced Molecular Therapy, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
  • Division of Gastroenterology, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.

ORCID-Profile: Fumihiro Sanada, Yoshiaki Taniyama, Koichi Yamamoto

Förderung

  • JSPS KAKENHI Grant
  • G7 Foundation
  • JSPS KAKENHI

Zitieren

APA

Tsunetoshi, Y., Sanada, F., Kanemoto, Y., Shibata, K., Masamune, A., Taniyama, Y., Yamamoto, K., & Morishita, R. (2024). A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313205

Vancouver

Tsunetoshi Y, Sanada F, Kanemoto Y, Shibata K, Masamune A, Taniyama Y, et al. A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313205

BibTeX
@article{Tsunetoshi2024,
  author = {Tsunetoshi, Yasuo and Sanada, Fumihiro and Kanemoto, Yuko and Shibata, Kana and Masamune, Atsushi and Taniyama, Yoshiaki and Yamamoto, Koichi and Morishita, Ryuichi},
  title = {A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252313205}
}
Kostenlos starten →